{"transactions":[{"id":945490,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:27:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526005024/ownership.xml","form_type":"4"}},{"id":1245082,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:07.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025027254/ownership.xml","form_type":"4"}},{"id":1313149,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:30:20.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025001568/ownership.xml","form_type":"4"}},{"id":1674902,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:16.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224003107/ownership.xml","form_type":"4"}},{"id":2065261,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":5000,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000222","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000222/ownership.xml","form_type":"4"}},{"id":2065260,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69925,"kind":"person","name":"Villalobos Anabella","position":1,"cik":"0001952966","reported_name":"Villalobos Anabella","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:17.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000222","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000222/ownership.xml","form_type":"4"}}]}